Subscribe to Newsletter

Refine results:

Refine results

Webinars on demand

Inside the Lab Digital and computational pathology

Comprehensive Opal Multiplex Validation: From Staining to Digital Image Analysis

| Sponsored by Akoya Biosciences

Optimisation and validation of a multiplex immunofluorescence workflow, from staining to digital image analysis, ensures assay robustness and prepares this technology for deployment in clinical trial analysis and in routine diagnostics.

Subspecialties Oncology

Exploring MSI Screening Technologies

| Sponsored by Promega

Microsatellite Instability (MSI)-High has been identified as a biomarker for immune checkpoint inhibitor therapy in cancers originating in different tissues.

Inside the Lab Precision medicine

Decision support software in the NGS oncology workflow

| Sponsored by Roche

An increasing number of clinical laboratories are using next generation sequencing (NGS) for the molecular characterization of cancer.

Inside the Lab Digital and computational pathology

Redefining Cancer Treatment: Targeting Gene Fusions

| Sponsored by Invitae

ArcherDX , now Invitae is a leading genomics company democratizing precision oncology.

Inside the Lab Digital and computational pathology

AI-based Digital Diagnostics for the Detection of Prostate Cancer

| Sponsored by Paige

Prostate cancer, the most frequently diagnosed cancer in 105 countries and the leading cause of death in 46 countries worldwide, is diagnosed by core needle biopsy.

Diagnostics Biochemistry and molecular biology

Standardizing minimal residual disease (MRD) assessment in lymphoid malignancies using NGS

| Sponsored by Adaptive Biotechnologies

clonoSEQ® Assay is a highly sensitive, specific, and standardized method for detecting and monitoring minimal residual disease (MRD).

Subspecialties Oncology

Validating a targeted NGS approach for molecular characterization of gliomas

| Sponsored by QIAGEN

Targeted NGS has been instrumental in driving our understanding of disease.

Outside the Lab Pathologists’ assistants

Pathologists’ Assistants: Bridging the Gap

The Pathologist is delighted to introduce the Pathologists’ Assistants: Bridging the Gap Live Roundtable.

Diagnostics Biochemistry and molecular biology

A new day for myeloid genomic profiling: how NGS advancements are providing deeper insight with faster time to results

| Sponsored by Thermo Fisher Scientific

The use of genomic profiling for myeloid samples has accelerated in recent years due in part to increasing annotation of disease-associated biomarkers.

Inside the Lab Digital and computational pathology

Digital Pathology for Routine Diagnostics: Experiences from Region Skåne & Hospital for Special Surgery

| Sponsored by Sectra

Region Skåne (Sweden) has implemented digital pathology in 4 labs across their enterprise.

Diagnostics Liquid biopsy

Comprehensive genomic profiling from liquid biopsy samples in clinical trials

| Sponsored by Illumina

Clinical trials are increasingly using liquid biopsy samples to complement or as an alternative to invasive tissue sample collections.

Diagnostics Companion diagnostics

Improving the Diagnostic Accuracy of the PD-L1 Test with Multiplexing and Image Analysis

| Sponsored by Ultivue

Targeting of the programmed cell death protein (PD-1)/ programmed death-ligand 1 (PD-L1) axis with checkpoint inhibitors has changed clinical practice in non-small cell lung cancer (NSCLC).

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine